William A. Faubion, M.D., is dual certified in pediatric and adult gastroenterology with nearly 20 years of experience, focusing on Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD). He also serves as Dean for Research in Arizona and is the Executive Director of the Center for Regenerative Biotherapeutics, an enterprise role. Dr. Faubion joined the staff of Mayo Clinic in 1999 and holds the academic rank of professor of immunology, medicine and pediatrics, Mayo Clinic College of Medicine and Science. Along with his clinical interests, he leads an NIH funded translational research laboratory that centers on examining how immune cells make “fate decisions” to become proinflammatory and cause the chronic intestinal inflammation of IBD. His extensive clinical research studies have evaluated the efficacy of novel therapeutics (including cell therapies) in adult and pediatric onset Crohn’s disease and ulcerative colitis as well as novel biomarkers predictive of active and complicated IBD.